Literature DB >> 18410458

Feasibility of prophylaxis and immune tolerance induction regimens in haemophilic children using fully implantable central venous catheters.

Maria Elisa Mancuso1, Pier Mannuccio Mannucci, Angelo Sartori, Andrea Agliardi, Elena Santagostino.   

Abstract

Venous access represents the major barrier to the feasibility of prophylaxis and immune tolerance induction (ITI) in haemophilic children. Ports improve treatment feasibility, but their duration is limited by infectious complications. This study aimed at evaluating whether or not ports allow haemophilic children to maintain the treatment regimen in the long term. Children were prospectively followed-up and underwent port removal either for complications or transition to peripheral veins. Of 27 ports (17 used for prophylaxis and 10 for ITI), 25 were removed after a median of 3.3 years. Inhibitor children showed a younger age at port insertion (P = 0.02), an earlier occurrence of infections (P = 0.006) at a higher rate (P = 0.00001) and an earlier removal for infection (P = 0.05) than non-inhibitor patients. Daily port use was associated with earlier infections at a higher rate compared to less frequent use (P = 0.02). Port removal after a median of 0.8 years prevented ITI completion in 50% of children, while it hampered the maintenance of prophylaxis in 27% of patients. This study showed that ports improved the feasibility of prophylaxis in the majority of non-inhibitor children, while they were not suitable for inhibitor children who require a prolonged ITI regimen with daily infusions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18410458     DOI: 10.1111/j.1365-2141.2008.07087.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  4 in total

Review 1.  Barriers to primary prophylaxis in haemophilic children: the issue of the venous access.

Authors:  Elena Santagostino; Maria Elisa Mancuso
Journal:  Blood Transfus       Date:  2008-09       Impact factor: 3.443

2.  Successful treatment of a spontaneous haemothorax with recombinant factor VIIa in a haemophilic child with inhibitors.

Authors:  D Gidaris; M Economou; R Valeri; N Gombakis; M Athanasiou-Metaxa
Journal:  Hippokratia       Date:  2010-10       Impact factor: 0.471

3.  Improved treatment feasibility in children with hemophilia using arteriovenous fistulae: the results after seven years of follow-up.

Authors:  Maria Elisa Mancuso; Luisa Berardinelli; Claudio Beretta; Mauro Raiteri; Ermanno Pozzoli; Elena Santagostino
Journal:  Haematologica       Date:  2009-03-13       Impact factor: 9.941

Review 4.  Non-factor therapies for bleeding disorders: A primer for the general haematologist.

Authors:  Dawn Swan; Johnny Mahlangu; Jecko Thachil
Journal:  EJHaem       Date:  2022-04-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.